Sailong Pharmaceutical GroupLtd Balance Sheet Health
Financial Health criteria checks 3/6
Sailong Pharmaceutical GroupLtd has a total shareholder equity of CN¥537.5M and total debt of CN¥127.2M, which brings its debt-to-equity ratio to 23.7%. Its total assets and total liabilities are CN¥784.3M and CN¥246.8M respectively. Sailong Pharmaceutical GroupLtd's EBIT is CN¥12.4M making its interest coverage ratio 1.9. It has cash and short-term investments of CN¥58.7M.
Key information
23.7%
Debt to equity ratio
CN¥127.21m
Debt
Interest coverage ratio | 1.9x |
Cash | CN¥58.69m |
Equity | CN¥537.51m |
Total liabilities | CN¥246.80m |
Total assets | CN¥784.31m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 002898's short term assets (CN¥231.1M) exceed its short term liabilities (CN¥200.2M).
Long Term Liabilities: 002898's short term assets (CN¥231.1M) exceed its long term liabilities (CN¥46.6M).
Debt to Equity History and Analysis
Debt Level: 002898's net debt to equity ratio (12.7%) is considered satisfactory.
Reducing Debt: 002898's debt to equity ratio has increased from 0% to 23.7% over the past 5 years.
Debt Coverage: 002898's debt is not well covered by operating cash flow (18.7%).
Interest Coverage: 002898's interest payments on its debt are not well covered by EBIT (1.9x coverage).